Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.

Chengcheng Yan Melissa A Richard Christopher J GibsonJianbo HeAlysia Kristine Bosworth David K Crossman Purnima SinghLindsey HagemanRashi KalraSaro H Armenian Julie M Vose Daniel J Weisdorf Benjamin L Ebert Yutaka Yasui Stephen J FormanRavi BhatiaSmita Bhatia

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

mutations in the PBSC product increases the risk of post-aPBSCT t-MN and nonrelapse mortality among patients with HL and may support alternative therapeutic strategies.

Keyphrases

hodgkin lymphoma
bone marrow
cell therapy
cardiovascular events
dendritic cells
acute myeloid leukemia
risk factors
platelet rich plasma
type diabetes
stem cells
mesenchymal stem cells
immune response
transition metal
drug induced